HomeFile

File

View Category
Antiplatelet

Antiplatelet Treatment with Ticagrelor vs. Clopidogrel in Patients with Chronic Coronary Syndrome

Achieving rapid and maximum inhibition of platelet aggregation can reduce complications related to scheduled percutaneous coronary intervention...
solaci -
Learn More
Chronic Coronary Syndromes

Glycemic Control and Coronary Stent Failure

Diabetic patients have twice as high a risk of developing coronary artery disease (CAD). Additionally, CAD increases...
solaci -
Learn More
Femoropopliteal

Sirolimus-Eluting Balloon in Femoropopliteal Disease

Drug-eluting balloons (DEB) with paclitaxel have shown efficacy and safety in the treatment of femoropopliteal disease. Sirolimus-eluting...
solaci -
Learn More
Coronary disease

Coronary Angioplasty with Sirolimus Eluting Stents

At present, most percutaneous coronary intervention procedures (PCI) are done with drug eluting stents (DES). However, drug...
solaci -
Learn More
Acute coronary syndromes

Patients with CABG History and new N-ST ACS: Routine Invasive Strategy?

Multiple studies support the use of an early invasive approach in high risk patients with non-ST elevation...
solaci -
Learn More
Structural heart disease

Low-Flow Aortic Stenosis: What is the Value of Valve Calcification in its Interpretation?

Delays in the treatment of symptomatic aortic stenosis (AS) reduce prognosis, especially in elderly patients. Accurate assessment...
solaci -
Learn More
Chronic Ischemic cardiopathy

Long Term Outcomes of Hyperemic Stenosis Resistance Index (HSR) in Patients with Stable Chronic Angina

The hyperemic stenosis resistance index (HSR) was introduced as a more complete hemodynamic severity indicator of a...
solaci -
Learn More
Coronary disease

BIONYX: Onyx vs. Orsiro At 5 Years

Onyx is a zotarolimus-eluting stent (ZES), designed with thin struts and a platinum core that enhances its...
solaci -
Learn More